MedPath

Do Probiotics Reduce The Risk Of Severe Necrotising Enterocolitis (NEC) In Infants Born Before 32 Weeks Gestation?

Conditions
Enterocolitis, Necrotizing
Interventions
Dietary Supplement: Probiotics
Registration Number
NCT06422988
Lead Sponsor
Imperial College London
Brief Summary

Necrotising enterocolitis (NEC) is one of the leading causes of mortality and morbidity in very preterm infants. This study aims to determine whether NEC rates are different between infants who receive probiotics versus infants who do not receive probiotics. The study has a retrospective cohort design and will utilise routinely collected data from the UK National Neonatal Research Database (NNRD). The cohort will comprise all infants born before 32 weeks gestation and cared for in neonatal units in England and Wales between 2016 and 2022. A propensity score matched approach will be used to conduct two comparisons: i) the risk of necrotising enterocolitis (NEC) between who do and those who do not receive probiotics in the first 14 days of life ii) the risk of NEC between babies who receive the two most common probiotic products used in UK units, (Labinic and Proprems).

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
48000
Inclusion Criteria
  • Eligible infants must have been born at less than 32 weeks gestation and be cared for in a English or Welsh unit which contributes data to the National Neonatal Research Database (this includes all NHS neonatal units in England and Wales).
  • Infants born in the period January 1st, 2016, to December 31st, 2022 (7 years) will be included.
Exclusion Criteria
  • They have missing data for any of: gestational age at birth, birth weight, year of birth and date of death (for those that died).
  • Their NNRD record does not include details of their first admission or begins after Day 3 of life.
  • The absolute value of their recorded birthweight for gestational age z score exceeds 4 or is missing.
  • They die in the first two postnatal days of life.
  • They have a major congenital abnormality

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
No probiotic exposureProbioticsDid not receive any probiotic in the first 14 days of life.
Exposed to probioticsProbioticsReceipt of any probiotic in the first 14 days of life. Probiotics to include: Labinic, Proprems probiotic, Acidophillus, Bifidobacterium, Bio-kult, Infloran, LB2. To address potential recording error, infants whose NNRD records show minimal (one day) of probiotic exposure will only be classed as exposed if they are cared for in a probiotic unit. Probiotic units are defined as: * units who have confirmed that a guideline was in place to provide probiotics to infants born before 32 weeks gestation and that the guideline was in place at any point in the year that the infant was born OR * units where more than 50% of the infants eligible to be part of the cohort received probiotics in the six months after the infant was born.
Primary Outcome Measures
NameTimeMethod
Severe necrotising enterocolitis (NEC)From date of birth until the date of discharge from final neonatal unit, assessed up to 24 months

NEC confirmed at surgery or postmortem or listed as a cause of death

Secondary Outcome Measures
NameTimeMethod
Pragmatically defined NECFrom date of birth until the date of discharge from final neonatal unit, assessed up to 24 months

Infants who had a recorded diagnosis of necrotising enterocolitis and received at least 5 consecutive days of antibiotics whilst also nil by mouth

Survival without severe NEC or late onset sepsis (LOS)From date of birth until the date of discharge from final neonatal unit, assessed up to 24 months

LOS is defined according to the Healthcare Quality Improvement Partnership (HQIP) National Neonatal Audit Programme (NNAP) case definition i.e. blood stream or cerebrospinal fluid confirmed pure growth in culture after first three days of life

Late onset sepsisFrom date of birth until the date of discharge from final neonatal unit, assessed up to 24 months

HQIP NNAP case definition

Pragmatically defined late onset sepsisFrom date of birth until the date of discharge from final neonatal unit, assessed up to 24 months

Growth of any organisms that appear in the NNAP lists of "Clearly pathogenic organisms" and "Other organisms"

Survival without any NECFrom date of birth until the date of discharge from final neonatal unit, assessed up to 24 months

NEC is defined as per the NNAP definition

Treated retinopathy of prematurityFrom date of birth until the date of discharge from final neonatal unit, assessed up to 24 months

Defined as cryotherapy, laser therapy or injection of anti-vascular endothelial growth factor therapy for ROP in either or both eyes

Necrotising enterocolitis (NNAP definition)From date of birth until the date of discharge from final neonatal unit, assessed up to 24 months

NEC diagnosed at postmortem or NEC diagnosed during surgery or NEC diagnosed using clinical and radiographic features (where the infant has at least one clinical feature (bilious gastric aspirate or emesis, abdominal distension, occult, gross blood in stool) and at least one radiographic feature (pneumatosis, hepato-biliary gas, pneumoperitoneum)).

Brain injuryFrom date of birth until the date of discharge from final neonatal unit, assessed up to 24 months

Either left or right grade 3 or higher intra-ventricular haemorrhage or cystic periventricular leukomalacia

Stage of retinopathy of prematurityFrom date of birth until the date of discharge from final neonatal unit, assessed up to 24 months
Bronchopulmonary dysplasia36 weeks postmenstrual age

Defined as any respiratory or ventilatory support or supplemental oxygen at 36 weeks postmenstrual age

Survival to discharge homeOn date of discharge from final neonatal unit, assessed up to 24 months
Severe bronchopulmonary dysplasia36 weeks postmenstrual age

Defined as ventilation via endotracheal tube or trachestomy, and excluding non-invasive support or CPAP, at 36 weeks postmenstrual age

Length of stayFrom date of birth until the date of discharge from final neonatal unit, assessed up to 24 months

Number of days between first neonatal unit admission and final neonatal unit discharge for surviving infants

Time to full feedsBefore discharge from final neonatal unit

Defined as the number of days until an infant is recorded as not requiring any parenteral nutrition or fluid (i.e. no parenteral nutrition or intravenous dextrose)

Growth36 weeks corrected gestational age

Weight for post-menstrual age standard deviation score

Trial Locations

Locations (1)

Imperial College

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath